Rapid itch reduction with ruxolitinib in mild-to-moderate atopic dermatitisSeptember 19, 2022Atopic Dermatitis
Brepocitinib shows potential against mild-to-moderate atopic dermatitis in phase 2 trialSeptember 19, 2022Atopic Dermatitis
Meta-analysis finds no increased VTE risk in AD patients receiving JAK inhibitorsSeptember 19, 2022Atopic Dermatitis
Dupilumab shows good drug survival in moderate-to-severe atopic dermatitisSeptember 19, 2022Atopic Dermatitis
Dermatology NewsBrodalumab suicide risk similar to other biologics, postmarket study findsSeptember 19, 2022PsoriasisPsoriatic ArthritisMixed Topics
Dermatology NewsHope shines bright for hidradenitis suppurativa treatmentsSeptember 19, 2022Medical Dermatology
Dermatology NewsPhysicians can’t be bystanders in ‘silent scourge’ of medical bullyingSeptember 19, 2022Business of MedicinePractice Management
Dermatology NewsQuiet quitting: Are physicians dying inside bit by bit? Or setting healthy boundaries?September 16, 2022Mixed Topics
Dermatology NewsMedical coding creates barriers to care for transgender patientsSeptember 16, 2022Business of Medicine
Dermatology NewsArtemisia capillaris extractSeptember 16, 2022Aesthetic DermatologyPigmentation DisordersPsoriasis
Dermatology NewsPandemic has helped clinicians to gain better insight on pernio, expert saysSeptember 16, 2022COVID-19 UpdatesInfectious Diseases
Dermatology NewsLow-dose oral minoxidil for the treatment of alopeciaSeptember 15, 2022Aesthetic DermatologyHair & Nails
